Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis

Circulation Research - Tập 118 Số 4 - Trang 620-636 - 2016
Michael A. Gimbrone1,2, Guillermo Garcı́a-Cardeña1,2
1Center for Excellence in Vascular Biology, BWH, 77 Ave Louis Pasteur, NRB-752, Boston, MA 02115.
2From the Department of Pathology, Center for Excellence in Vascular Biology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA.

Tóm tắt

Dysfunction of the endothelial lining of lesion-prone areas of the arterial vasculature is an important contributor to the pathobiology of atherosclerotic cardiovascular disease. Endothelial cell dysfunction, in its broadest sense, encompasses a constellation of various nonadaptive alterations in functional phenotype, which have important implications for the regulation of hemostasis and thrombosis, local vascular tone and redox balance, and the orchestration of acute and chronic inflammatory reactions within the arterial wall. In this review, we trace the evolution of the concept of endothelial cell dysfunction, focusing on recent insights into the cellular and molecular mechanisms that underlie its pivotal roles in atherosclerotic lesion initiation and progression; explore its relationship to classic, as well as more recently defined, clinical risk factors for atherosclerotic cardiovascular disease; consider current approaches to the clinical assessment of endothelial cell dysfunction; and outline some promising new directions for its early detection and treatment.

Từ khóa


Tài liệu tham khảo

10.1111/j.1749-6632.1987.tb33025.x

10.1016/j.carpath.2012.06.006

10.1161/01.ATV.20.5.1177

10.1161/01.ATV.20.5.1262

Simionescu N, Vasile E, Lupu F, Popescu G, Simionescu M. Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol. 1986;123:109–125.

10.1126/science.180.4093.1332

10.1056/NEJM197608122950707

10.1161/01.ATV.1.5.293

10.1056/NEJM198602203140806

10.1038/362801a0

10.1056/NEJM199901143400207

10.1083/jcb.201412052

10.1038/nature01323

10.1056/NEJMra043430

10.1038/nri1882

10.1161/01.CIR.94.8.2013

10.1161/01.ATV.0000261709.34878.20

10.1016/j.jacc.2005.03.074

10.1056/NEJMc1307806

10.1093/eurheartj/ehv044

Strong GM. The Udana: The solemn utterances of the Buddha. London: Forgotten Books; 1902.

10.1007/978-3-662-36692-9

Palade GE. Fine structure of blood capillaries. J Appl Physiol. 1953;24.

10.1083/jcb.35.1.213

Majno G. Ultrastructure of the vascular membrane. In: , Hamilton WF, Dox P, eds. Handbook of Physiology: Section 2, Circulation. Washington, DC:American Physiological Society; 1965.

Cotran R. The Fine Structure of the Microvasculature in Relation to Normal and Altered Permeability. Philadelphia, WB Saunders Co; 1967.

Majno G. The Healing Hand. Man and Wound in the Ancient World. Cambridge: University Press; 1975.

10.1111/j.1749-6632.1982.tb25702.x

Gimbrone MA Culture of vascular endothelium. Prog Hemost Thromb. 1976;3:1–28.

Gimbrone MA Vascular endothelium in health & disease. In: , Haber E, ed. Molecular Cardiovascular Medicine. New York: Scientific American; 1994:49–62.

Gimbrone MA Vascular Endothelium in Hemostasis & Thrombosis. Edinburgh: Churchill Livingstone; 1986.

10.1152/physrev.1995.75.3.519

10.1152/physrev.00047.2009

10.1016/S0002-9149(02)03144-2

Gimbrone MA. Atherogenesis: current concepts. In: , Schoen FJ, Gimbrone MA, ed. Cardiovascular Pathology Clincopathologic Correlations and Pathogenic Mechanisms. Baltimore, MD: William & Wilkens; 1995:1–11.

10.1161/01.CIR.0000131515.03336.f8

10.1002/9780470988473

Virchow R. Der ateromatose prozess der arterien. Wien Med Wochenschr. 1856:825–827.

10.1016/0014-4800(74)90082-3

10.1016/0021-9150(73)90031-2

Gerrity RG, Naito HK, Richardson M, Schwartz CJ. Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages. Am J Pathol. 1979;95:775–92.

10.1111/j.1749-6632.1990.tb42271.x

10.1161/01.RES.36.1.58

10.1016/0021-9150(75)90059-3

10.1016/0021-9150(75)90015-5

Gimbrone MAJ. Endothelial Dysfunction and the Pathogenesis of Atherosclerosis, Proceedings of the Fifth International Symposium. New York: Springer-Verlag; 1980.

Gimbrone MA Vascular endothelium and atherosclerosis. In: , Moore S, ed. Vascular Injury and Atherosclerosis. New York: Marcel Dekker; 1981:25–52.

10.1126/science.1138377

10.1016/0049-3848(77)90185-2

10.1098/rstb.1994.0023

Weitz J. Hemostasis, thrombosis, fibrinolysis and cardiovascular disease. In: , Zipes DP, Libby P, Bonow RO, ed. Braunwald’s Heart Disease. Philadelphia, PA: Elsevier Saunders; 2015:1809–1833.

Libby P, Ordovas JM, Auger KR, Robbins AH, Birinyi LK, Dinarello CA. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol. 1986;124:179–185.

10.1038/288373a0

10.1038/308645a0

Rubanyi GM, Lorenz RR, Vanhoutte PM. Bioassay of endothelium-derived relaxing factor(s): inactivation by catecholamines. Am J Physiol. 1985;249:H95–101.

Martin W, Villani GM, Jothianandan D, Furchgott RF. Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins. J Pharmacol Exp Ther. 1985;233:679–685.

10.1161/01.RES.52.3.352

10.1073/pnas.84.24.9265

10.1073/pnas.071054698

10.1016/0014-2999(87)90563-2

10.1111/j.1476-5381.1987.tb11310.x

10.1038/333664a0

10.1016/S0021-9258(19)49528-8

10.1172/JCI116092

10.1242/jcs.01165

10.1016/j.cardiores.2007.03.023

10.1152/ajpcell.1994.266.3.C628

10.1074/jbc.R111.285742

10.1084/jem.185.4.601

10.1242/jcs.03361

10.1016/S0092-8674(03)00803-1

10.1126/science.279.5348.234

10.1126/science.276.5321.2034

10.1172/JCI62854

10.1146/annurev.pharmtox.39.1.191

10.1038/377239a0

10.1073/pnas.93.23.13176

10.1152/ajpcell.00546.2002

10.1016/S0146-0005(00)80064-6

10.1161/hc2901.091399

10.1056/NEJM198610233151702

10.1161/01.RES.58.6.783

10.1172/JCI112779

10.1161/hs1101.097393

10.1016/0002-9149(95)80017-M

10.1097/00007890-199010000-00001

10.1152/physrev.1990.70.2.427

10.1038/nri2171

10.1073/pnas.79.21.6641

10.1073/pnas.84.24.9238

10.1126/science.2688092

Rollins BJ, Yoshimura T, Leonard EJ, Pober JS. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol. 1990;136:1229–1233.

10.1084/jem.164.2.661

Munro JM, Pober JS, Cotran RS. Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Pathol. 1989;135:121–133.

10.1126/science.1990440

10.1016/0092-8674(89)90775-7

10.1084/jem.171.4.1369

10.1016/0092-8674(90)90661-W

10.1172/JCI116670

10.1161/01.RES.85.2.199

10.1161/01.ATV.18.5.842

10.1161/01.ATV.13.2.197

10.1172/JCI115932

10.1161/01.ATV.17.11.2646

10.1172/JCI11871

10.1161/hq1201.100220

10.1161/ATVBAHA.108.179697

10.1161/CIRCULATIONAHA.108.827618

10.1161/ATVBAHA.115.305324

10.1016/j.jacc.2006.08.011

10.1172/JCI10373

10.1073/pnas.90.10.4591

10.1073/pnas.97.16.9052

10.1016/j.molcel.2014.08.024

10.1161/01.CIR.97.18.1837

10.1001/jama.297.6.611

10.1161/CIRCULATIONAHA.108.814251

10.1038/nature10146

10.1016/0021-9150(76)90009-5

Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med. 1988;112:1018–1031.

10.1115/1.2895545

10.1098/rspb.1971.0019

10.1016/0033-0620(75)90009-2

10.1063/1.1136909

10.1115/1.3138276

10.1115/1.1486468

10.1126/science.3883488

10.3233/BIR-1984-21419

10.1115/1.3138567

Zand T, Nunnari JJ, Hoffman AH, Savilonis BJ, MacWilliams B, Majno G, Joris I. Endothelial adaptations in aortic stenosis. Correlation with flow parameters. Am J Pathol. 1988;133:407–418.

10.1152/ajpcell.00187.2012

10.1126/science.6681677

10.1146/annurev.bioeng.9.060906.151959

10.1161/ATVBAHA.114.303415

10.1073/pnas.83.7.2114

10.1161/01.RES.83.6.636

10.1073/pnas.96.6.3154

10.1161/01.ATV.12.11.1254

10.1161/ATVBAHA.113.301826

10.1111/j.1749-6632.1994.tb17312.x

10.1002/jcp.1041430222

10.1006/bbrc.1994.2813

10.1073/pnas.91.11.4678

10.1172/JCI117787

10.1172/JCI119219

10.1172/JCI119346

10.1074/jbc.M307528200

10.1152/ajpcell.1997.273.5.C1506

10.1073/pnas.93.19.10417

10.1016/S1357-4310(98)01372-0

10.1161/01.ATV.18.5.677

10.1001/jama.282.21.2035

10.1073/pnas.071052598

10.1073/pnas.171259298

10.1152/physiolgenomics.2001.7.1.55

10.1073/pnas.0406073101

10.1073/pnas.0305938101

10.1007/s10439-007-9400-0

10.1093/cvr/cvt101

10.1182/blood-2002-01-0046

10.1172/JCI24787

10.1016/S0002-9440(10)63002-7

10.1182/blood-2005-08-3465

10.1161/JAHA.113.000290

10.1161/ATVBAHA.110.211474

10.1161/ATVBAHA.114.304277

10.1038/ncb2441

10.1172/JCI74281

10.1161/CIRCRESAHA.108.184663

10.1074/jbc.C500144200

10.1161/CIRCULATIONAHA.104.525774

10.1016/j.bbagen.2015.03.011

10.1146/annurev.pharmtox.45.120403.095748

10.1056/NEJMoa0807646

10.1161/ATVBAHA.114.303428

10.1016/j.bbrc.2009.12.002

10.4049/jimmunol.1400571

10.1074/jbc.M110.103127

10.1172/JCI66056

10.1161/CIRCRESAHA.107.152942

10.1186/1423-0127-16-12

10.1371/journal.pone.0022892

10.1161/ATVBAHA.109.193375

10.1161/ATVBAHA.108.165811

10.1055/s-0037-1616937

10.1038/nrcardio.2015.38

10.1161/ATVBAHA.115.305043

10.1073/pnas.1002120107

10.1073/pnas.0914882107

10.1161/ATVBAHA.114.303473

10.1016/j.bbrc.2012.09.026

10.1161/CIRCULATIONAHA.110.005108

10.1152/ajpheart.00829.2010

10.1038/ncomms4000

10.1242/jcs.154252

10.1161/ATVBAHA.111.244053

10.1161/CIRCRESAHA.114.302213

10.1172/JCI74792

10.1007/s12195-014-0325-z

10.1161/CIRCRESAHA.115.303883

10.1016/S0741-5214(99)70249-1

10.1161/01.RES.74.2.349

10.1152/japplphysiol.90553.2008

10.1016/j.jacc.2007.02.059

10.1161/01.CIR.0000080882.35274.AD

10.1093/eurheartj/ehl575

10.1161/CIRCULATIONAHA.111.021824

10.1161/CIRCULATIONAHA.112.096438

10.1093/cvr/cvs217

10.1016/j.atherosclerosis.2015.03.017

10.1016/j.atherosclerosis.2013.11.049

Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 2005;1:183–198.

Libby P, Gerszten RE, Ridker PM. Biomarkers, proteomics, metabolomics, and personalized medicine. In: , Zipes DP, Libby P, Bonow RO, eds. Braunwald’s Heart Disease. 10th ed. Philadelphia, PA: Elsevier, Saunders; 2015:84–93.

10.2967/jnumed.109.069633

10.1007/s12265-014-9582-4

10.1038/nature06796

10.1093/eurheartj/eht022

10.1056/NEJM199704033361401

10.1056/NEJM200003233421202

10.1001/jama.286.1.64

10.1056/NEJMoa042378

10.1017/CBO9780511546198

10.1038/nri2921

Ridker P, Libby P, Buring J. Risk markers and the primary prevention of cardiovascular disease. In: , Zipes DP, Libby P, Bonow RO, eds. Braunwald’s Heart Disease. 10th ed. Philadelphia, PA: Elsevier, Saunders; 2015.

10.1007/s11154-014-9301-0

10.1016/j.cmet.2010.12.008

10.1172/JCI36233

10.1161/CIRCRESAHA.116.302855

10.15252/emmm.201404156

Ginsburg G. Personalized and precision cardiovascular medicine. In: , Zipes DP, Libby P, Bonow RO, eds. Braunwald’s Heart Disease. 10th ed. Philadelphia, PA: Elsevier, Saunders; 2015:57–63.

Altschul R. Endothelium: Its Development, Morphology, Function and Pathology. New York, NY: The Macmillan Co; 1954.